Aurinia Pharmaceuticals (AUPH) Interest Coverage Ratio (2023 - 2026)

Aurinia Pharmaceuticals (AUPH) has 8 years of Interest Coverage Ratio data on file, last reported at 40.93 in Q1 2026.

• Quarterly Interest Coverage Ratio rose 15314.78% year-over-year to 40.93 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 35.93 (down 9819.57% YoY) and the FY2025 annual result came in at 1.94, up 6493.57% from the prior year.
• Interest Coverage Ratio advanced to 40.93 in Q1 2026, from 15.23 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 40.93 in Q1 2026 to a low of 248.77 in Q2 2023.
• A 5-year average of 30.3 and a median of 0.49 in 2022 frame the typical range for Interest Coverage Ratio.
• Annual changes were most pronounced in 2023 — Interest Coverage Ratio tumbled 23061.3% — and 2025, when it surged 16612.0%.
• Tracing AUPH's Interest Coverage Ratio over 5 years: stood at 23.42 in 2022, then tumbled by 329.57% to 100.59 in 2023, then surged by 100.64% to 0.64 in 2024, then slumped by 2461.95% to 15.23 in 2025, then surged by 368.82% to 40.93 in 2026.
• The last three Interest Coverage Ratio figures came in at 40.93 (Q1 2026), 15.23 (Q4 2025), and 4.14 (Q3 2025), per Business Quant data.